Nausea and Vomiting in Pregnancy (NVP)

Without management, severe nausea and vomiting during pregnancy (NVP) can jeopardize the physical and emotional health of a woman and impact her unborn infant. Approximately 50 percent of women experience NVP to some extent, with up to 2 percent of women having severe NVP (hyperemesis) requiring long-term and aggressive treatment of the condition.

Alere’s Nausea and Vomiting in Pregnancy Program provides home-based treatment, early intervention and an appropriate program of continuous subcutaneous medication via microinfusion pump and nutrition for patients experiencing this condition. As a result, patients require fewer antepartum hospitalizations and emergency room visits, which reduces overall healthcare costs.

Alere follows a critical pathway approach to patient care. Critical pathways include:

• Hydration therapy
• Antiemetic therapy
• Total intravenous nutrition

View the Nausea and Vomiting in Pregnancy Program Overview for a more complete overview of the program.